Pharmacological or genetic inhibition of LTCC promotes cardiomyocyte proliferation through inhibition of calcineurin activity.
Devilée LAC, Salama ABM, Miller JM, Reid JD, Ou Q, Baraka NM, Abou Farraj K, Jamal M, Nong Y, Rosengart TK, Andres D, Satin J, Mohamed TMA, Hudson JE, Abouleisa RRE.
Devilée LAC, et al. Among authors: miller jm.
NPJ Regen Med. 2025 Jan 11;10(1):1. doi: 10.1038/s41536-025-00389-z.
NPJ Regen Med. 2025.
PMID: 39799185